Kennedy Capital Management, Inc. Delcath Systems, Inc. Transaction History
Kennedy Capital Management, Inc.
- $3.95 Billion
- Q2 2025
A detailed history of Kennedy Capital Management, Inc. transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 319,047 shares of DCTH stock, worth $3.47 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
319,047
Previous 292,130
9.21%
Holding current value
$3.47 Million
Previous $3.72 Million
16.7%
% of portfolio
0.11%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding DCTH
# of Institutions
121Shares Held
13.2MCall Options Held
108KPut Options Held
40.5K-
Vanguard Group Inc Valley Forge, PA1.61MShares$17.5 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY813KShares$8.84 Million0.25% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il803KShares$8.74 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA703KShares$7.65 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA570KShares$6.2 Million1.64% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $93.5M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...